California Public Employees Retirement System Sells 16,400 Shares of Catalent Inc (CTLT)
California Public Employees Retirement System cut its position in shares of Catalent Inc (NYSE:CTLT) by 8.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,080 shares of the company’s stock after selling 16,400 shares during the quarter. California Public Employees Retirement System owned approximately 0.12% of Catalent worth $5,397,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the company. Quantamental Technologies LLC purchased a new position in shares of Catalent in the 4th quarter valued at approximately $47,000. Enlightenment Research LLC purchased a new position in shares of Catalent in the 4th quarter valued at approximately $56,000. First Bank & Trust lifted its stake in shares of Catalent by 13.9% in the 4th quarter. First Bank & Trust now owns 4,600 shares of the company’s stock valued at $143,000 after purchasing an additional 563 shares during the period. Chicago Equity Partners LLC purchased a new position in shares of Catalent in the 3rd quarter valued at approximately $237,000. Finally, Ramsey Quantitative Systems purchased a new position in shares of Catalent in the 4th quarter valued at approximately $194,000. Hedge funds and other institutional investors own 98.80% of the company’s stock.
In other news, SVP Lance Miyamoto sold 43,619 shares of the business’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $42.49, for a total value of $1,853,371.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP William Downie sold 7,315 shares of the business’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $42.00, for a total value of $307,230.00. The disclosure for this sale can be found here. 1.40% of the stock is owned by insiders.
Catalent (NYSE:CTLT) last announced its quarterly earnings data on Tuesday, February 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.08. The business had revenue of $623.00 million during the quarter, compared to analysts’ expectations of $608.38 million. Catalent had a return on equity of 17.42% and a net margin of 5.48%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 earnings per share. As a group, research analysts anticipate that Catalent Inc will post 1.69 EPS for the current year.
A number of research analysts have recently commented on the company. Zacks Investment Research cut Catalent from a “buy” rating to a “hold” rating in a research note on Thursday, February 7th. ValuEngine upgraded Catalent from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. First Analysis restated an “outperform” rating and issued a $49.00 target price on shares of Catalent in a research note on Tuesday, March 5th. Morgan Stanley set a $46.00 target price on Catalent and gave the company a “buy” rating in a research note on Monday, December 3rd. Finally, TheStreet upgraded Catalent from a “c” rating to a “b-” rating in a research note on Wednesday, February 6th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Catalent currently has a consensus rating of “Buy” and a consensus target price of $47.88.
TRADEMARK VIOLATION WARNING: This story was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://theolympiareport.com/2019/03/15/california-public-employees-retirement-system-sells-16400-shares-of-catalent-inc-ctlt.html.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
Featured Story: What is Put Option Volume?
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.